GNRH1 and adenomyosis: As expected, ultrasound-guided percutaneous RFA combined with GnRH-a reduced menstrual volume, VAS score, and uterine volume, achieved a total effective rate of 100%, lowered hormone levels and CA125 level, reduced the rate of recurrence, and improved pregnancy outcomes in adenomyosis patients.